News

Cathy Collins Joins Panoramic Health Board for Growth Support

Cathy Collins Joins Panoramic Health Board for Growth Support

Cathy Collins Joins Panoramic Health Board to Propel Innovation

In the evolving landscape of kidney care, Panoramic Health has announced a significant enhancement to its leadership team with the appointment of Cathy Collins to its Board of Directors. This move aims to bolster the strategic direction of Panoramic Science, the company's community-focused clinical research network that conducts vital industry-sponsored trials.

Strengthening Clinical Research Capabilities

Collins, recognized for her extensive experience in clinical research, is poised to make a profound impact on Panoramic Science. Her background includes over three decades of navigating the complexities of clinical trials across various therapeutic areas. Collins previously held prestigious roles such as the Chief Executive Officer of research organizations and has a wealth of knowledge in site operations, network strategies, and sponsor relationships.

Collins' Experience and Vision

Before joining Panoramic Health, Collins was a key player at Headlands Research, where she was Senior Vice President of Site Strategy and Interim CEO. Her leadership during a critical growth phase enabled Headlands to succeed and expand significantly. This wealth of experience equips her to address the challenges and opportunities facing Panoramic Science in the rapidly growing cardiovascular-renal-metabolic (CVRM) sector.

Advancing Patient-Centric Research

Panoramic Science operates over 20 research sites throughout the United States, dedicating itself to comprehensive research in the CVRM space. The organization's roots in nephrology position it uniquely to facilitate advancements in studies related to kidney disease, diabetes, and obesity. By partnering independently with nephrologists, Panoramic empowers these specialists to participate actively in groundbreaking clinical research while enhancing their practices.

Leadership Quotes and Perspectives

Lisa Kiehne, President of Panoramic Science, expresses enthusiasm regarding Collins’ addition, highlighting her robust operational insight and board-level experience as key components for Panoramic Science's growth. “Cathy will be essential in guiding us as we expand our focus across more areas of CVRM,” Kiehne said.

Committing to Future Growth

Collins’ appointment signifies Panoramic Health’s unwavering commitment to not only strengthen its research capabilities but also to enhance the quality of trials. “I'm excited to support the team as they broaden their influence while maintaining the quality standards vital for our sponsors and patients,” Collins noted, reflecting her vision for the future of clinical research.

A Multidisciplinary Approach

In addition to the board expansion, Panoramic Health’s commitment to quality is evident in its establishment of a Scientific Advisory Board featuring esteemed experts in nephrology and research. This group is pivotal in shaping innovative research strategies, ultimately benefiting patient care and community health.

About Panoramic Health

Panoramic Health stands as a leader in integrated kidney care, pioneering innovations that support nephrology practices. By empowering providers with advanced clinical and operational solutions, the organization significantly improves the quality of life for patients. Founded by nephrologists for nephrologists, Panoramic Health is deeply committed to maintaining clinical autonomy while fostering growth and reducing administrative burdens.

This integrated model is designed to meet the unique needs of complex kidney patients, ultimately allowing partner practices to elevate care quality and explore new growth avenues while keeping patient well-being at the forefront.

Frequently Asked Questions

What role will Cathy Collins play at Panoramic Health?

Cathy Collins will serve on the Board of Directors, focusing on advising and advancing the clinical research avenues at Panoramic Science.

What is Panoramic Health's focus area?

Panoramic Health is dedicated to integrated kidney care and is a leader in clinical research within the cardiovascular-renal-metabolic therapeutic domain.

How does Panoramic Science support nephrologists?

Panoramic Science provides independent nephrologists with opportunities to engage in clinical research and access innovative solutions to enhance their practices.

What is the significance of Collins' appointment?

Collins' extensive experience and leadership are expected to drive the growth and operational efficiency of Panoramic Science, enhancing its research capabilities.

How does Panoramic Health ensure quality in clinical trials?

Through a multidisciplinary approach and collaboration with experts, Panoramic Health is committed to delivering high-quality trials that meet evolving sponsor needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 43

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Lives: A Look at Xinjiang's Aratax Dam Project

Updated Category News Views 287

Transforming Communities Through the Aratax Dam In the mountainous region where the Yarkand River flows, there was a time when residents faced severe challenges during the rainy season. Flooding was a frequent and destructive occurrence, threatening homes, crops, and entire communities. The memories of such natural disasters still linger in the minds of locals. However,...

Continue Reading
Join Securitas for an Insightful Capital Markets Day in 2026

Updated Category News Views 208

Join Securitas for an Insightful Capital Markets Day in 2026 Mark your calendars for June 16, 2026, as Securitas extends a warm invitation to investors, analysts, and financial media for its much-anticipated Capital Markets Day. This significant event will unfold at the prestigious London Stock Exchange, offering attendees a detailed overview of Securitas' strategic...

Continue Reading
Discover High-Yield Monthly Dividend Funds for a Bright 2025

Updated Category News Views 213

The Allure of Closed-End Funds and Their Yields Many investors find closed-end funds (CEFs) attractive primarily due to their impressive dividends. The average yield of 8.7% offered by these funds can play a significant role in retirement planning, ensuring a steady income stream. Besides the attractive yields, CEFs provide access to a diverse array of assets, such as...

Continue Reading
Investors Alert: Class Action Opportunities for Major Companies

Updated Category News Views 118

Understanding Class Action Lawsuits Class action lawsuits serve as an important tool for investors who believe they have suffered significant losses due to fraudulent activities of publicly traded companies. These lawsuits not only provide a collective approach to seeking justice but also offer an opportunity for shareholders to hold companies accountable for misleading...

Continue Reading
Davidson Kempner Analysis of Aviva's Shareholding Trends

Updated Category News Views 267

Understanding Davidson Kempner Capital Management LP's Position on Aviva plc In a recent disclosure, Davidson Kempner Capital Management LP made significant waves regarding their positions in Aviva plc. Attention has been drawn to their practices as they hold a considerable stake in the company. Key Information from the Disclosure The form provides essential information...

Continue Reading